UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031587
Receipt number R000036068
Scientific Title Examination of continuous ingestion of drink containing plant extract. N-18003
Date of disclosure of the study information 2018/03/09
Last modified on 2018/09/03 17:19:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of continuous ingestion of drink containing plant extract. N-18003

Acronym

Examination of continuous ingestion of drink containing plant extract. N-18003

Scientific Title

Examination of continuous ingestion of drink containing plant extract. N-18003

Scientific Title:Acronym

Examination of continuous ingestion of drink containing plant extract. N-18003

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Cardiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of plant extract on vascular function and autonomic nerve activity.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin temperature.

Key secondary outcomes

Peripheral blood flow, subjective evaluation and autonomic nerve activity.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Continuous ingestion of drink containing plant extract

Interventions/Control_2

Continuous ingestion of placebo drink not containing plant extract

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

30 years-old >=

Gender

Female

Key inclusion criteria

1.Healthy adults
2.Person who agrees not to ingest specified foods and supplements during the test period.

Key exclusion criteria

1.Person whose diastolic blood pressures are more than 90mmHg and systolic ones are more than 140mmHg.
2.Person who has severe allergic disease as rhinitis, atopicdermatitis.
3.Person who is pregnant, lactating or planned to become pregnant during the test period.
4.Patient with vascular function disorder.
5.Person who has problems with electrocardiogram test such as arrhythmia.
6.Person who takes medicine.
7.Person who regularly goes to hospital or went to the medical institution within a month.
8.Current smoker.
9.Person who plans to participate in the other clinical studies.
10.Person who is judged as unsuitable for the study by the investigator for other reasons.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yamamoto Noriyuki

Organization

Japanese Red Cross Hokkaido College of Nursing

Division name

Department of Health Sciences, Professor

Zip code


Address

1-664 Akebono Kitami Hokkaido

TEL

+81-157-66-3390

Email

yama@rchokkaido-cn.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukinori Nakashima

Organization

Kao Corporation

Division name

R&D-Skin Care Products Research

Zip code


Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan

TEL

+81-3-5630-9581

Homepage URL


Email

nakashima.yukinori@kao.com


Sponsor or person

Institute

Japanese Red Cross Hokkaido College of Nursing

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 23 Day

Date of IRB


Anticipated trial start date

2018 Year 03 Month 12 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 05 Day

Last modified on

2018 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036068


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name